Anti-diabetic drug dispute leads to ICC award
The biopharmaceuticals arm of Merck has secured damages from a French spin-off company in an ICC arbitration over royalties owed under agreements to develop an anti-diabetic drug.
To read more
Subscribe to Global Arbitration Review
Subscribe and start reading now
Global Arbitration Review (GAR) is the online home for international arbitration specialists, telling them everything they need to know about all the developments that matter.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10